Rhythm Biotherapeutics
PrivateLast Round
Seed
Dec 5, 2025
Total Funding Raised
$4.31M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rhythm Biotherapeutics Inc. is a biotechnology company developing exosome-based therapies to prevent and cure atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rhythm Biotherapeutics Comparables
Compare Rhythm Biotherapeutics with similar companies based on industry and business-model similarity.
Rhythm Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 5, 2025 | ||||
| Grant | Nov 15, 2024 | ||||
| Seed | Nov 15, 2024 |
Rhythm Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital BioVentures | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 5, 2025
Raised $4M in seed funding.
- Nov 15, 2024
$235K round led by Ken Newport
Rhythm Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rhythm Biotherapeutics's valuation, stock price, and market status.